Clinical trial
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis…
NCT00211887 · Fred Lublin, Other · Completed
Key facts
| NCT number | NCT00211887 |
|---|---|
| Title | Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx |
| Official title | A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Patients With Relapsing-Remitting Multiple Sclerosis (CombiRx) |
| Lead sponsor | Fred Lublin, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Relapsing Remitting Multiple Sclerosis |
| Intervention type | Drug, Other |
| Interventions | Interferon beta 1-a, glatiramer acetate, placebo |
| Enrollment | 1,008 |
| Start date | Jan 1, 2005 |
| Primary completion | Apr 1, 2012 |
| Completion | Mar 1, 2013 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 3, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: